🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/11/2009 | 45,84 | 46,11 | 45,19 | 45,59 | -0,33% | 2,01% | 470.900 |
| 27/11/2009 | 44,84 | 46,23 | 44,70 | 45,74 | -0,13% | 3,41% | 177.500 |
| 25/11/2009 | 45,34 | 46,04 | 45,23 | 45,80 | +0,66% | 1,79% | 457.800 |
| 24/11/2009 | 44,84 | 45,56 | 44,61 | 45,50 | +1,79% | 2,12% | 422.400 |
| 23/11/2009 | 45,37 | 45,99 | 44,32 | 44,70 | -0,47% | 3,68% | 711.700 |
| 20/11/2009 | 44,50 | 45,08 | 44,25 | 44,91 | +0,22% | 1,87% | 627.100 |
| 19/11/2009 | 44,94 | 44,99 | 44,41 | 44,81 | -1,04% | 1,29% | 671.400 |
| 18/11/2009 | 44,83 | 45,49 | 44,70 | 45,28 | +1,30% | 1,76% | 642.300 |
| 17/11/2009 | 43,39 | 44,80 | 43,20 | 44,70 | +2,31% | 3,69% | 812.900 |
| 16/11/2009 | 42,04 | 43,70 | 41,81 | 43,69 | +4,70% | 4,50% | 487.200 |
| 13/11/2009 | 42,39 | 42,81 | 41,51 | 41,73 | -1,09% | 3,07% | 432.200 |
| 12/11/2009 | 43,12 | 43,27 | 42,14 | 42,19 | -2,65% | 2,62% | 340.800 |
| 11/11/2009 | 43,16 | 43,45 | 42,73 | 43,34 | +0,21% | 1,67% | 465.800 |
| 10/11/2009 | 42,82 | 43,35 | 42,51 | 43,25 | +0,39% | 1,96% | 366.100 |
| 09/11/2009 | 43,35 | 43,35 | 42,40 | 43,08 | +0,19% | 2,19% | 380.400 |
| 06/11/2009 | 42,79 | 43,57 | 42,27 | 43,00 | -0,35% | 3,04% | 515.000 |
| 05/11/2009 | 43,04 | 43,68 | 42,92 | 43,15 | +1,22% | 1,77% | 712.400 |
| 04/11/2009 | 42,99 | 43,62 | 42,50 | 42,63 | -0,16% | 2,61% | 554.400 |
| 03/11/2009 | 41,91 | 42,80 | 41,81 | 42,70 | +1,02% | 2,36% | 359.100 |
| 02/11/2009 | 42,52 | 43,00 | 42,01 | 42,27 | -0,63% | 2,33% | 643.700 |
| 30/10/2009 | 43,04 | 43,70 | 42,36 | 42,54 | -2,00% | 3,11% | 932.800 |
| 29/10/2009 | 41,28 | 43,57 | 41,00 | 43,41 | +6,84% | 6,23% | 1.719.500 |
| 28/10/2009 | 42,11 | 42,11 | 40,33 | 40,63 | -3,63% | 4,23% | 794.100 |
| 27/10/2009 | 41,61 | 42,36 | 41,45 | 42,16 | +1,32% | 2,19% | 484.900 |
| 26/10/2009 | 42,47 | 42,68 | 41,37 | 41,61 | -2,28% | 3,08% | 382.000 |
| 23/10/2009 | 42,33 | 42,95 | 41,99 | 42,58 | +0,54% | 2,27% | 791.600 |
| 22/10/2009 | 41,52 | 42,41 | 41,11 | 42,35 | +2,29% | 3,13% | 435.400 |
| 21/10/2009 | 42,06 | 42,79 | 41,36 | 41,40 | -1,38% | 3,40% | 982.900 |
| 20/10/2009 | 44,30 | 44,50 | 41,74 | 41,98 | -5,45% | 6,23% | 1.511.500 |
| 19/10/2009 | 45,05 | 45,27 | 44,27 | 44,40 | -1,33% | 2,22% | 559.800 |